未登录

D

Denggao Yao

university of glasgow

H指数:16

被引数:857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain-Barre syndrome

由超自然膜损伤引起的轴突纳米结构引起的小鼠格林-巴利综合征继发性轴突变性

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

IF3.2

2023-02-128

OAAI

Complement inhibition prevents glial nodal membrane injury in a GMI antibody-mediated mouse model

BRAIN COMMUNICATIONS

IF4.5

2022-11-238

OAAI

Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barre syndrome mouse model

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2022-07-1516

OAAI

Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain-Barre syndrome

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

IF3.2

2020-04-2024

OAAI

Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis

IF11.7

2016-03-2629

OAAI

C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2016-03-0260

OAAI

PTEN ablation in RasHa/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition

RasHa/Fos皮肤癌变中的PTEN消融会引起p53-dependent p21延迟转化，而p53-independent p21通过细胞周期蛋白D1/E2抑制作用限制进展

IF7.3

2013-09-1611

OAAI

Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21WAF-induced differentiation triggered by GSK3β inactivation and reduced AKT activity

JOURNAL OF CELL SCIENCE

IF3.6

2008-05-1519

OAAI

PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways

CANCER RESEARCH

IF16.6

2006-02-0130

OAAI

Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins

BIOCHEMICAL PHARMACOLOGY

IF5.6

2004-01-0166

PREAI

Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man

BIOCHEMICAL PHARMACOLOGY

IF5.6

2002-12-01164

PREAI

Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways

BIOCHEMICAL JOURNAL

IF4.3

2001-06-0117

OAAI

Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: An intralaboratory comparison

DRUG METABOLISM REVIEWS

IF3.8

1999-12-0537

PREAI

High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

1997-12-0134

PREAI